Consolidated Statements of Income and Comprehensive Income - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Revenue:
Medicine	$ 11,506,041	$ 9,400,113
Patient services	32,885,130	26,306,084
Total revenue	44,391,171	35,706,197
Operating costs and expenses:
Cost of medicine sold	9,094,776	6,796,711
Medical consumables	11,103,377	8,338,807
Salaries and benefits	11,871,813	8,374,223
Office supplies	1,201,472	1,630,623
Vehicle expenses	328,341	233,720
Utilities expenses	704,658	624,352
Rentals and leases	1,155,662	223,949
Advertising and promotion expenses	35,817	130,246
Interest expense	1,381,761	1,137,445
Professional fee	97,701	109,562
Convertible notes expense		(322,363)
Warrant expense	(1,142)	139,467
Depreciation	3,313,827	2,696,065
Total operating costs and expenses	40,288,063	30,112,807
Earnings from operations before other income and income taxes	4,103,108	5,593,390
Other income (expenses)	266,957	(396,497)
Earnings from operations before income taxes	4,370,065	5,196,893
Income tax	1,181,120	1,369,615
Net income	3,188,945	3,827,278
Less: net income attributable to non-controlling interests	956,684	1,148,183
Net income attributable to the Company	2,232,261	2,679,095
Other comprehensive income:
Foreign currency translation adjustment attributable to non-controlling interests	274,917	485,881
Foreign currency translation adjustment attributable to the Company	656,465	1,125,857
Comprehensive income	4,120,327	5,439,016
Less: Comprehensive income attributable to non-controlling interests	1,231,601	1,634,064
Comprehensive income attributable to the Company	$ 2,888,726	$ 3,804,952
Basic earnings per share (in Dollars per share)	$ 0.121	$ 0.1483
Diluted earnings per share (in Dollars per share)	$ 0.1196	$ 0.1466
Weighted average number of shares outstanding (Basic) (in Shares)	18,451,588	18,060,070
Weighted average number of shares outstanding (Diluted) (in Shares)	18,661,588	18,270,070